Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MIR133B | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mir133b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MIR133B | CTD | PMID:39978740 | MIR133B | Human | 6-propyl-2-thiouracil | increases expression | ISO | Mir133b (Mus musculus) | 6480464 | Propylthiouracil results in increased expression of MIR133B mRNA | CTD | PMID:20808432 | MIR133B | Human | amphetamine | increases expression | ISO | Mir133b (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of MIR133B mRNA | CTD | PMID:30779732 | MIR133B | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of MIR133B mRNA | CTD | PMID:22072212 | MIR133B | Human | atorvastatin calcium | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of MIR133B mRNA | CTD | PMID:29679711 | MIR133B | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of MIR133B promoter | CTD | PMID:27901495 | MIR133B | Human | bleomycin A2 | decreases expression | ISO | Mir133b (Rattus norvegicus) | 6480464 | Bleomycin results in decreased expression of MIR133B mRNA | CTD | PMID:25933445 | MIR133B | Human | cadmium atom | multiple interactions | ISO | Mir133b (Rattus norvegicus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR133B more ... | CTD | PMID:33652105 | MIR133B | Human | cadmium atom | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR133B more ... | CTD | PMID:28892167 | MIR133B | Human | cadmium dichloride | multiple interactions | ISO | Mir133b (Rattus norvegicus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR133B more ... | CTD | PMID:33652105 | MIR133B | Human | cadmium dichloride | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR133B more ... | CTD | PMID:28892167 | MIR133B | Human | ciprofloxacin | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of MIR133B mRNA | CTD | PMID:29679711 | MIR133B | Human | cisplatin | increases expression | ISO | Mir133b (Rattus norvegicus) | 6480464 | Cisplatin results in increased expression of MIR133B mRNA | CTD | PMID:24880025 | MIR133B | Human | cisplatin | increases response to substance | EXP | | 6480464 | MIR133B mRNA results in increased susceptibility to Cisplatin | CTD | PMID:32052927 | MIR133B | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of MIR133B mRNA | CTD | PMID:22072212 | MIR133B | Human | gemfibrozil | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of MIR133B mRNA | CTD | PMID:30853469 | MIR133B | Human | lovastatin | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of MIR133B mRNA | CTD | PMID:30853469 | MIR133B | Human | methimazole | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Methimazole co-treated with perchlorate] results in increased expression of MIR133B mRNA | CTD | PMID:20808432 | MIR133B | Human | nickel atom | multiple interactions | ISO | Mir133b (Rattus norvegicus) | 6480464 | [nickel sulfate results in increased abundance of Nickel] which results in increased expression of MIR133B more ... | CTD | PMID:31734292 | MIR133B | Human | nickel sulfate | multiple interactions | ISO | Mir133b (Rattus norvegicus) | 6480464 | [nickel sulfate results in increased abundance of Nickel] which results in increased expression of MIR133B more ... | CTD | PMID:31734292 | MIR133B | Human | paracetamol | decreases expression | ISO | Mir133b (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of MIR133B mRNA | CTD | PMID:19246379 | MIR133B | Human | perchlorate | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Methimazole co-treated with perchlorate] results in increased expression of MIR133B mRNA | CTD | PMID:20808432 | MIR133B | Human | perfluorooctane-1-sulfonic acid | increases expression | ISO | Mir133b (Rattus norvegicus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of MIR133B mRNA | CTD | PMID:24420840 | MIR133B | Human | perfluorooctanoic acid | increases expression | ISO | Mir133b (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of MIR133B mRNA | CTD | PMID:28126411 | MIR133B | Human | pioglitazone | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Pioglitazone co-treated with Buthionine Sulfoximine] results in increased expression of MIR133B mRNA | CTD | PMID:28263783 | MIR133B | Human | quercetin | decreases expression | ISO | Mir133b (Rattus norvegicus) | 6480464 | Quercetin results in decreased expression of MIR133B mRNA | CTD | PMID:26432773 | MIR133B | Human | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MIR133B mRNA | CTD | PMID:25605016 | MIR133B | Human | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | Mir133b (Mus musculus) | 6480464 | [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of MIR133B mRNA; more ... | CTD | PMID:28263783|PMID:29679711|PMID:30853469 | MIR133B | Human | tetrachloromethane | decreases expression | ISO | Mir133b (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of MIR133B mRNA | CTD | PMID:27397436 | MIR133B | Human | titanium dioxide | increases expression | ISO | Mir133b (Mus musculus) | 6480464 | titanium dioxide results in increased expression of MIR133B mRNA | CTD | PMID:21259345 | MIR133B | Human | valproic acid | increases expression | ISO | Mir133b (Mus musculus) | 6480464 | Valproic Acid results in increased expression of MIR133B mRNA | CTD | PMID:24896083 | MIR133B | Human | zinc atom | decreases expression | ISO | Mir133b (Rattus norvegicus) | 6480464 | Zinc deficiency results in decreased expression of MIR133B mRNA | CTD | PMID:22689922 | MIR133B | Human | zinc(0) | decreases expression | ISO | Mir133b (Rattus norvegicus) | 6480464 | Zinc deficiency results in decreased expression of MIR133B mRNA | CTD | PMID:22689922 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





















